Evidence map›Paper›PMID 32503845›Full record

ArticleGut2021

SETDB1 is required for intestinal epithelial differentiation and the prevention of intestinal inflammation.

Lea Južnić, Kenneth Peuker, Anne Strigli, Mario Brosch, Alexander Herrmann, Robert Häsler, Michael Koch, Liz Matthiesen, Yvonne Zeissig, Britt-Sabina Löscher and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Gut, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 86 citations in OpenAlex.

  1. Inflammatory bowel disease and breast cancer: epidemiological evidence, shared biology, and clinical management.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 1 country.

Lea Južnić *Department of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
Kenneth Peuker *Department of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
Anne StrigliDepartment of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
Mario BroschDepartment of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
Alexander HerrmannDepartment of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
Robert HäslerInstitute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany.
Michael KochDepartment of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
Liz MatthiesenDepartment of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
Yvonne ZeissigDepartment of General Pediatrics, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
Britt-Sabina LöscherInstitute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany.ORCID 0000-0001-9022-9017
Alexander NuberDivision of Molecular Biology, Biomedical Center, Faculty of Medicine, Ludwig Maximilians University Munich, Munich, Germany.
Gunnar SchottaDivision of Molecular Biology, Biomedical Center, Faculty of Medicine, Ludwig Maximilians University Munich, Munich, Germany.
Volker NeumeisterInstitute for Clinical Chemistry and Laboratory Medicine, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
Triantafyllos ChavakisInstitute for Clinical Chemistry and Laboratory Medicine, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.
Thomas KurthCenter for Molecular and Cellular Bioengineering (CMBC), Technology Platform, Technische Universität (TU) Dresden, Dresden, Germany.
Mathias LescheDRESDEN-concept Genome Center, c/o Center for Molecular and Cellular Bioengineering (CMCB), Technische Universität (TU) Dresden, Dresden, Germany.
Andreas DahlDRESDEN-concept Genome Center, c/o Center for Molecular and Cellular Bioengineering (CMCB), Technische Universität (TU) Dresden, Dresden, Germany.
Anne von MässenhausenBIOTEChnology Center, Technische Universität (TU) Dresden, Dresden, Germany.
Andreas LinkermannBIOTEChnology Center, Technische Universität (TU) Dresden, Dresden, Germany.
Stefan SchreiberInstitute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany.
Konrad AdenInstitute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany.
Philip C RosenstielInstitute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany.
Andre FrankeInstitute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany.ORCID 0000-0003-1530-5811
Jochen HampeDepartment of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany.ORCID 0000-0002-2421-6127
Sebastian ZeissigDepartment of Medicine I, University Medical Center Dresden, Technische Universität (TU) Dresden, Dresden, Germany sebastian.zeissig@tu-dresden.de.ORCID 0000-0001-5124-0897
Technische Universität Dresden · DEChristian-Albrechts-Universität zu Kiel · DECenter for Systems Biology Dresden · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe intestinal epithelium is a rapidly renewing tissue which plays central roles in nutrient uptake, barrier function and the prevention of intestinal inflammation. Control of epithelial differentiation is essential to these processes and is dependent on cell type-specific activity of transcription factors which bind to accessible chromatin. Here, we studied the role of SET Domain Bifurcated Histone Lysine Methyltransferase 1, also known as ESET (SETDB1), a histone H3K9 methyltransferase, in intestinal epithelial homeostasis and IBD.

designWe investigated mice with constitutive and inducible intestinal epithelial deletion of

resultsDeletion of intestinal epithelial

conclusionSETDB1 plays an essential role in intestinal epithelial homeostasis. Future work is required to investigate whether rare variants in

Indexed as

AnimalsCell DifferentiationEpithelial CellsFemaleGene SilencingHistone-Lysine N-MethyltransferaseHomeostasisHumansInflammatory Bowel DiseasesIntestinal MucosaLoss of Function MutationMaleMiceHistone-Lysine N-MethyltransferaseSETDB1 protein, humanSETDB1 protein, mouseepithelial differentiationgut inflammationIBDIBD - geneticsintestinal epithelium

Identifiers

PMID32503845
PMCPMC7873423
OpenAlexW3034112755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.